Evidence map›Paper›PMID 41775695›Full record

ArticleNature communications2026

Non-chelation control in allylations of α-oxy ketones using group-14 allylatranes.

Yuya Tsutsui, Kokoro Shiga, Akihito Konishi, Makoto Yasuda

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kokoro ShigaDepartment of Applied Chemistry, Graduate School of Engineering, The University of Osaka, 2-1 Yamadaoka, Suita, Osaka, Japan.ORCID http://orcid.org/0009-0006-8448-8139
Akihito KonishiDepartment of Applied Chemistry, Graduate School of Engineering, The University of Osaka, 2-1 Yamadaoka, Suita, Osaka, Japan. a-koni@chem.eng.osaka-u.ac.jp.ORCID http://orcid.org/0000-0002-3438-786X
Makoto YasudaDepartment of Applied Chemistry, Graduate School of Engineering, The University of Osaka, 2-1 Yamadaoka, Suita, Osaka, Japan. yasuda@chem.eng.osaka-u.ac.jp.ORCID http://orcid.org/0000-0002-6618-2893

Funding

MEXT | Japan Science and Technology Agency (JST) JPMJFR2426MEXT | Japan Society for the Promotion of Science (JSPS) JP23H01950MEXT | Japan Society for the Promotion of Science (JSPS) JP25K22182MEXT | JST | Core Research for Evolutional Science and Technology (CREST) JPMJCR20R3Ministry of Education, Culture, Sports, Science and Technology (MEXT) JP21H05212Ministry of Education, Culture, Sports, Science and Technology (MEXT) JP23H04028
6 · The paper itself

Abstract

Stereoselective nucleophilic additions to α-substituted carbonyl compounds are a crucial area of contemporary research in organic chemistry. Of the various advancements in π-facial selectivity in addition reactions of carbonyl compounds, the (polar) Felkin-Anh model and the chelation model are well recognized for accurately explaining the selectivity of the allylic products. For reactions that involve α-oxy carbonyl groups - known for their broad applications in natural-product synthesis and as effective building blocks in organic synthesis - the stereoselective reaction typically follows the chelation model, favoring syn-selective addition. In contrast to the well-established syn-selective additions of α-oxy carbonyls, anti-selective additions through a non-chelation pathway remain largely unexplored. In this study, we present the anti-selective allylation of α-oxy ketones using allylatranes that feature a highly coordinated group-14-element center. These atranes demonstrate high nucleophilicity and low chelating ability due to their transannular interactions and rigid framework, facilitating anti-selective allylations. A combined experimental and theoretical approach has been used to highlight the unique electronic properties of these atranes. This method is applicable to a wide variety of substrates, producing anti-1,2-diols with a homoallylic moiety in high yield and excellent diastereoselectivity compared to traditional methods.

Identifiers

PMID41775695
PMCPMC12957295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.